bosentan anhydrous has been researched along with ozagrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ishiguro, S; Miyamoto, A; Nishio, A | 1 |
2 other study(ies) available for bosentan anhydrous and ozagrel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Stimulation of bradykinin B2-receptors on endothelial cells induces relaxation and contraction in porcine basilar artery in vitro.
Topics: Animals; Basilar Artery; Bosentan; Bradykinin; Bradykinin Receptor Antagonists; Endothelium, Vascular; Female; In Vitro Techniques; Indomethacin; Male; Masoprocol; Methacrylates; Nitroarginine; Papaverine; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Sulfonamides; Swine; Thromboxane A2; Thromboxanes; Vasoconstriction; Vasodilation | 1999 |